Covalon leverages its patented medical technology platforms and expertise in two ways; (i) we develop products that we sell under Covalon's name; and (ii) we develop and commercialize medical products for other medical companies under development and license contracts.
The Majority of Covalon-branded products are sold through independent distributors to various health care providers such as hospitals, wound care centers, burn centres, extended/alternate care facilities, acute care facilities, home health care agencies, and physicians' offices. Our products require regulatory clearances and are sold on prescription basis in the United States, Canada, and a number of international countries.
Covalon currently has three proprietary platform technologies that have the potential to be developed into dozens of medical devices: (i) Collagen matrix; (ii) Antimicrobial silicone adhesive; and (iii) Medical coating technology. These platform technologies are protected by patents, patent applications and patents pending, patented and proprietary manufacturing processes, trade secrets, brands, trademarks, and trade names.
Member Since: 2014